Maha Dalal

Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivity

David A. Cooney, Maha Dalal, Hiroaki Mitsuya et al. · Biochemical Pharmacology · 1986 · 322 citations

Medicine, Htlv-iii Infectivity, Antiviral Drug Development +8

The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.

Jan Balzarini, Gil-Jong Kang, Maha Dalal et al. · Molecular Pharmacology · 1987 · 234 citations

Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity

Gurpreet S. Ahluwalia, David A. Cooney, Hiroaki Mitsuya et al. · Biochemical Pharmacology · 1987 · 147 citations

Molecular Pharmacology, Hiv Infectivity, Medicine +9

Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidine

Jan Balzarini, Rudi Pauwels, Piet Herdewijn et al. · Biochemical and Biophysical Research Communications · 1986 · 130 citations

Medicinal Chemistry, Derivative (Chemistry), Bioorganic Chemistry +12

Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity

David A. Cooney, Gurpreet S. Ahluwalia, Hiroaki Mitsuya et al. · Biochemical Pharmacology · 1987 · 102 citations

Medicine, Htlv-iii Infectivity, Antiviral Drug Development +8